Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Phytochemistry ; 154: 94-105, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30031244

ABSTRACT

Antimicrobial peptides (AMPs), the self-defence products of organisms, are extensively distributed in plants. They can be classified into several groups, including thionins, defensins, snakins, lipid transfer proteins, glycine-rich proteins, cyclotides and hevein-type proteins. AMPs can be extracted and isolated from different plants and plant organs such as stems, roots, seeds, flowers and leaves. They perform various physiological defensive mechanisms to eliminate viruses, bacteria, fungi and parasites, and so could be used as therapeutic and preservative agents. Research on AMPs has sought to obtain more detailed and reliable information regarding the selection of suitable plant sources and the use of appropriate isolation and purification techniques, as well as examining the mode of action of these peptides. Well-established AMP purification techniques currently used include salt precipitation methods, absorption-desorption, a combination of ion-exchange and reversed-phase C18 solid phase extraction, reversed-phase high-performance liquid chromatography (RP-HPLC), and the sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) method. Beyond these traditional methods, this review aims to highlight new and different approaches to the selection, characterisation, isolation, purification, mode of action and bioactivity assessment of a range of AMPs collected from plant sources. The information gathered will be helpful in the search for novel AMPs distributed in the plant kingdom, as well as providing future directions for the further investigation of AMPs for possible use on humans.


Subject(s)
Antimicrobial Cationic Peptides/isolation & purification , Plants/chemistry , Antimicrobial Cationic Peptides/chemistry , Chromatography, High Pressure Liquid , Electrophoresis, Polyacrylamide Gel
2.
J Pharm Biomed Anal ; 149: 591-602, 2018 Feb 05.
Article in English | MEDLINE | ID: mdl-29197806

ABSTRACT

The sharp increase in incidence of dengue infection has necessitated the development of methods for the rapid diagnosis of this deadly disease. Here we report the design and development of a reliable, sensitive, and specific optical immunosensor for the detection of the dengue nonstructural protein 1 (NS1) biomarker in clinical samples obtained during early stages of infection. The present optical NS1 immunosensor comprises a biosensing surface consisting of specific monoclonal NS1 antibody for immunofluorescence-based NS1 antigen determination using fluorescein isothiocyanate (FITC) conjugated to IgG antibody. The linear range of the optical immunosensor was from 15-500ngmL-1, with coefficient of determination (R2) of 0.92, high reproducibility (the relative standard deviation obtained was 2%), good stability for 21days at 4°C, and low detection limit (LOD) at 15ngmL-1. Furthermore, the optical immunosensor was capable of detecting NS1 analytes in plasma specimens from patients infected with the dengue virus, with low cross-reaction with plasma specimens containing the Japanese encephalitis virus (JEV) and Zika virus. No studies have been performed on the reproducibility and cross-reactivity regarding NS1 specificity, which is thus a limitation for optical NS1 immunosensors. In contrast, the present study addressed these limitations carefully where these two important experiments were conducted to showcase the robustness of our newly developed optical-based fluorescence immunosensor, which can be practically used for direct NS1 determination in any untreated clinical sample.


Subject(s)
Biosensing Techniques/methods , Dengue Virus/immunology , Dengue/diagnosis , Viral Nonstructural Proteins/isolation & purification , Antibodies, Monoclonal/immunology , Biomarkers/analysis , Cross Reactions/immunology , Dengue/blood , Dengue/virology , Dengue Virus/isolation & purification , Encephalitis Virus, Japanese/immunology , Encephalitis Virus, Japanese/isolation & purification , Encephalitis, Japanese/blood , Encephalitis, Japanese/virology , Fluorescent Antibody Technique/methods , Humans , Reproducibility of Results , Sensitivity and Specificity , Viral Nonstructural Proteins/blood , Viral Nonstructural Proteins/immunology , Zika Virus/immunology , Zika Virus/isolation & purification , Zika Virus Infection/blood , Zika Virus Infection/virology
3.
J Transl Med ; 15(1): 121, 2017 05 31.
Article in English | MEDLINE | ID: mdl-28569153

ABSTRACT

BACKGROUND: Currently, several assays can diagnose acute dengue infection. However, none of these assays can predict the severity of the disease. Biomarkers that predicts the likelihood that a dengue patient will develop a severe form of the disease could permit more efficient patient triage and allows better supportive care for the individual in need, especially during dengue outbreaks. METHODS: We measured 20 plasma markers i.e. IFN-γ, IL-10, granzyme-B, CX3CL1, IP-10, RANTES, CXCL8, CXCL6, VCAM, ICAM, VEGF, HGF, sCD25, IL-18, LBP, sCD14, sCD163, MIF, MCP-1 and MIP-1ß in 141 dengue patients in over 230 specimens and correlate the levels of these plasma markers with the development of dengue without warning signs (DWS-), dengue with warning signs (DWS+) and severe dengue (SD). RESULTS: Our results show that the elevation of plasma levels of IL-18 at both febrile and defervescence phase was significantly associated with DWS+ and SD; whilst increase of sCD14 and LBP at febrile phase were associated with severity of dengue disease. By using receiver operating characteristic (ROC) analysis, the IL-18, LBP and sCD14 were significantly predicted the development of more severe form of dengue disease (DWS+/SD) (AUC = 0.768, P < 0.0001; AUC = 0.819, P < 0.0001 and AUC = 0.647, P = 0.014 respectively). Furthermore, we also found that the levels of VEGF were directly correlated and sCD14 was inversely correlated with platelet count, suggesting that the endothelial activation and microbial translocation may played a role in pathogenesis of dengue disease. CONCLUSIONS: Given that the elevation IL-18, LBP and sCD14 among patients with severe form of dengue disease, our findings suggest a pathogenic role for an aberrant inflammasome and monocyte activation in the development of severe form of dengue disease.


Subject(s)
Dengue/blood , Dengue/immunology , Monocytes/cytology , Severe Dengue/blood , Severe Dengue/immunology , Acute-Phase Proteins , Adult , Area Under Curve , Biomarkers/blood , Carrier Proteins/blood , Cytokines/metabolism , Dengue/diagnosis , Dengue Virus , Disease Outbreaks , Female , Humans , Inflammasomes , Inflammation , Interleukin-18/blood , Lipopolysaccharide Receptors/blood , Longitudinal Studies , Male , Membrane Glycoproteins/blood , Platelet Count , ROC Curve , Severe Dengue/diagnosis , Young Adult
4.
Front Microbiol ; 7: 1841, 2016.
Article in English | MEDLINE | ID: mdl-27920759

ABSTRACT

Influenza viruses belong to the family Orthomyxoviridae of enveloped viruses and are an important cause of respiratory infections worldwide. The influenza virus is able to infect a wide variety species as diverse as poultry, marine, pigs, horses, and humans. Upon infection with influenza virus the innate immunity plays a critical role in efficient and rapid control of viral infections as well as in adaptive immunity initiation. The humoral immune system produces antibodies against different influenza antigens, of which the HA-specific antibody is the most important for neutralization of the virus and thus prevention of illness. Cell mediated immunity including CD4+ helper T cells and CD8+ cytotoxic T cells are the other arms of adaptive immunity induced upon influenza virus infection. The complex inherited factors and age related changes are associated with the host immune responses. Here, we review the different components of immune responses against influenza virus. Additionally, the correlation of the immune response to age and inherited factors has been discussed. These determinations lead to a better understanding of the limitations of immune responses for developing improved vaccines to control influenza virus infection.

5.
J Food Drug Anal ; 24(4): 855-865, 2016 10.
Article in English | MEDLINE | ID: mdl-28911625

ABSTRACT

Chemotherapies remain far from ideal due to drug resistance; therefore, novel chemotherapeutic agents with higher effectiveness are crucial. The extracts of four Phyllanthus species, namely Phyllanthus niruri, Phyllanthus urinaria, Phyllanthus watsonii, and Phyllanthus amarus, were shown to induce apoptosis and inhibit metastasis of breast carcinoma cells (MCF-7). The main objective of this study was to determine the pathways utilized by these four Phyllanthus species to exert anti-metastatic activities. A cancer 10-pathway reporter was used to investigate the pathways affected by the four Phyllanthus species. Results indicated that these Phyllanthus species suppressed breast carcinoma metastasis and proliferation by suppressing matrix metalloprotein 2 and 9 expression via inhibition of the extracellular signal-related kinase (ERK) pathway. Additionally, inhibition of hypoxia-inducible factor 1-α in the hypoxia pathway caused reduced vascular endothelial growth factor and inducible nitric oxide synthase expression, resulting in anti-angiogenic effects and eventually anti-metastasis. Two-dimensional gel electrophoresis identified numerous proteins suppressed by these Phyllanthus species, including invasion proteins, anti-apoptotic protein, protein-synthesis proteins, angiogenic and mobility proteins, and various glycolytic enzymes. Our results indicated that ERK and hypoxia pathways are the most likely targets of the four Phyllanthus species for the inhibition of MCF-7 metastasis.


Subject(s)
Breast Neoplasms , Cell Hypoxia , Humans , MAP Kinase Signaling System , MCF-7 Cells , Phyllanthus , Plant Extracts , Vascular Endothelial Growth Factor A
6.
Cell Immunol ; 297(1): 19-32, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26071876

ABSTRACT

The role of T-cell immunosenescence and functional CD8(+) T-cell responses in HIV/TB co-infection is unclear. We examined and correlated surrogate markers of HIV disease progression with immune activation, immunosenescence and differentiation using T-cell pools of HIV/TB co-infected, HIV-infected and healthy controls. Our investigations showed increased plasma viremia and reduced CD4/CD8 T-cell ratio in HIV/TB co-infected subjects relative to HIV-infected, and also a closer association with changes in the expression of CD38, a cyclic ADP ribose hydrolase and CD57, which were consistently expressed on late-senescent CD8(+) T cells. Up-regulation of CD57 and CD38 were directly proportional to lack of co-stimulatory markers on CD8(+) T cells, besides diminished expression of CD127 (IL-7Rα) on CD57(+)CD4(+) T cells. Notably, intracellular IFN-γ, perforin and granzyme B levels in HIV-specific CD8(+) T cells of HIV/TB co-infected subjects were diminished. Intracellular CD57 levels in HIV gag p24-specific CD8(+) T cells were significantly increased in HIV/TB co-infection. We suggest that HIV-TB co-infection contributes to senescence associated with chronic immune activation, which could be due to functional insufficiency of CD8(+) T cells.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Cellular Senescence/immunology , HIV Infections/immunology , Immunosenescence/immunology , Tuberculosis, Pulmonary/immunology , ADP-ribosyl Cyclase 1/biosynthesis , Adult , CD4-CD8 Ratio , CD57 Antigens/biosynthesis , CD57 Antigens/metabolism , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/pathology , Cell Differentiation/immunology , Cell Proliferation , Coinfection/immunology , Disease Progression , Female , Granzymes/metabolism , HLA-DR alpha-Chains/immunology , Humans , Interferon-gamma/metabolism , Interleukin-7 Receptor alpha Subunit/biosynthesis , Lymphocyte Activation/immunology , Male , Membrane Glycoproteins/biosynthesis , Perforin/metabolism
7.
PLoS One ; 9(4): e93056, 2014.
Article in English | MEDLINE | ID: mdl-24691130

ABSTRACT

Oxalate toxicity is mediated through generation of reactive oxygen species (ROS) via a process that is partly dependent on mitochondrial dysfunction. Here, we investigated whether C-phycocyanin (CP) could protect against oxidative stress-mediated intracellular damage triggered by oxalate in MDCK cells. DCFDA, a fluorescence-based probe and hexanoyl-lysine adduct (HEL), an oxidative stress marker were used to investigate the effect of CP on oxalate-induced ROS production and membrane lipid peroxidation (LPO). The role of CP against oxalate-induced oxidative stress was studied by the evaluation of mitochondrial membrane potential by JC1 fluorescein staining, quantification of ATP synthesis and stress-induced MAP kinases (JNK/SAPK and ERK1/2). Our results revealed that oxalate-induced cells show markedly increased ROS levels and HEL protein expression that were significantly decreased following pre-treatment with CP. Further, JC1 staining showed that CP pre-treatment conferred significant protection from mitochondrial membrane permeability and increased ATP production in CP-treated cells than oxalate-alone-treated cells. In addition, CP treated cells significantly decreased the expression of phosphorylated JNK/SAPK and ERK1/2 as compared to oxalate-alone-treated cells. We concluded that CP could be used as a potential free radical-scavenging therapeutic strategy against oxidative stress-associated diseases including urolithiasis.


Subject(s)
Cytoprotection/drug effects , Mitochondria/pathology , Oxalates/toxicity , Oxidative Stress/drug effects , Phycocyanin/pharmacology , Adenosine Triphosphate/metabolism , Animals , Cell Survival/drug effects , Dogs , Enzyme Activation/drug effects , Lipid Peroxidation/drug effects , Madin Darby Canine Kidney Cells , Membrane Potential, Mitochondrial/drug effects , Mitochondria/drug effects , Mitochondria/metabolism , Mitogen-Activated Protein Kinases/metabolism , Protective Agents/pharmacology , Reactive Oxygen Species/metabolism
8.
J Glob Infect Dis ; 3(3): 233-40, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21887054

ABSTRACT

BACKGROUND: Rapid and early dengue diagnosis is essential for patient management and early disease intervention. MP Diagnostics ASSURE(®) Dengue IgA Rapid Test (Dengue IgA RT) was developed for the rapid detection of anti-dengue IgA in patients' biological samples. The performance of Dengue IgA RT was examined using multiple categories of well-characterized samples. MATERIALS AND METHODS: Dengue IgA RT was designed and developed. Following characterization of samples by reference ELISAs, the performance of the kit was evaluated. RESULTS: The overall sensitivity and specificity of Dengue IgA RT were 86.70% (n=233) and 86.05% (n=681) respectively; in which Dengue IgA RT detected 77.42% primary and 92.86% secondary cases; compared to 70.97% and 72.14% by IgM-Cap ELISA and 89.25% and 20% by Non-Structural Protein 1 (NS1) Ag ELISA respectively. Using 125 paired samples, Dengue IgA RT showed 84.80% sensitivity at acute phase and 99.20% sensitivity at convalescent phase; with 92% specificity at both phases. Dengue IgA RT also demonstrated a consistent performance (sensitivity: 85.53%, specificity: 80%) with 76 whole blood samples. In detecting all four serotypes of DENV (n=162), the performance of Dengue IgA RT was comparable with in-house IgM-Cap ELISA. Kinetics of anti-dengue IgA production was elucidated with 42.86% detection level as early as one-two days after fever onset, which increased to 83.33% between five and seven days after fever onset. CONCLUSION: Dengue IgA RT demonstrated a good performance and is applicable as one of the dengue early diagnostic tools at all levels of health care system.

9.
Emerg Infect Dis ; 15(3): 436-40, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19239758

ABSTRACT

Anti-dengue virus immunoglobulin M kits were evaluated. Test sensitivities were 21%-99% and specificities were 77%-98% compared with reference ELISAs. False-positive results were found for patients with malaria or past dengue infections. Three ELISAs showing strong agreement with reference ELISAs will be included in the World Health Organization Bulk Procurement Scheme.


Subject(s)
Antibodies, Viral/blood , Dengue Virus/immunology , Dengue/diagnosis , Immunoglobulin M/blood , Reagent Kits, Diagnostic , Dengue/virology , Enzyme-Linked Immunosorbent Assay , False Positive Reactions , Humans , Reproducibility of Results , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...